Prime Medicine
PRME
PRME
116 hedge funds and large institutions have $266M invested in Prime Medicine in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
25% less capital invested
Capital invested by funds: $354M → $266M (-$88.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
116
Holding in Top 10
1
Calls
$2.28M
Puts
$249K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$2.4M | |
| 3 | +$605K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$585K |
| 5 |
Goldman Sachs
New York
|
+$545K |
Top Sellers
| 1 | -$4.6M | |
| 2 | -$1.8M | |
| 3 | -$1.4M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.34M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$714K |